Formulation, Development and Evaluation of Lopinavir Loaded Polymeric Micelles

{"title":"Formulation, Development and Evaluation of Lopinavir Loaded\nPolymeric Micelles","authors":"","doi":"10.46243/jst.2020.v5.i4.pp173-187","DOIUrl":null,"url":null,"abstract":"Lopinavir is the anti HIV drug which is used to treat the HIV-1 infection. In this study we used the single\nlopinavir drug to formulate the polymeric micelle. This study was done with the two main objectives as\nObjective:first to enhance the solubility and bioavailability of the BCS class IV drug and second to avoid the\ncombination of lopinavir rand ritonavir and use single lopinavir to preparation of polymeric micelle also to avoid\nthe disadvantages related to the oral administration. Method:The different pluronic (F188 &F127) and co-solvent\n(Tween80) were chosen & the micelles were prepared by using different Drug: polymer ratio with or without cosolvent and drug Lopinavir. Formulations were been characterized by critical micelle concentration(CMC) value,\nmicellesize,DSC, XRD, loading efficiency, % drug loading and stability.Result:Mixed micelle (hydrophobic\n&hydrophilic) obtained from optimized batch shows the highest entrapment of 29%with the pluronic F68 with the\nuse of co-solvent and the vesicle size of 0.156µm the DSC, FTIR, XRD study was also done for lopinavir and\noptimized formulation .Conclusion: The pluronic F68 with the co-solvent showed fairly high entrapment efficiency,\nloading capacity than the mixed Pluronic in combination","PeriodicalId":23534,"journal":{"name":"Volume 5, Issue 4","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Volume 5, Issue 4","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46243/jst.2020.v5.i4.pp173-187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Lopinavir is the anti HIV drug which is used to treat the HIV-1 infection. In this study we used the single lopinavir drug to formulate the polymeric micelle. This study was done with the two main objectives as Objective:first to enhance the solubility and bioavailability of the BCS class IV drug and second to avoid the combination of lopinavir rand ritonavir and use single lopinavir to preparation of polymeric micelle also to avoid the disadvantages related to the oral administration. Method:The different pluronic (F188 &F127) and co-solvent (Tween80) were chosen & the micelles were prepared by using different Drug: polymer ratio with or without cosolvent and drug Lopinavir. Formulations were been characterized by critical micelle concentration(CMC) value, micellesize,DSC, XRD, loading efficiency, % drug loading and stability.Result:Mixed micelle (hydrophobic &hydrophilic) obtained from optimized batch shows the highest entrapment of 29%with the pluronic F68 with the use of co-solvent and the vesicle size of 0.156µm the DSC, FTIR, XRD study was also done for lopinavir and optimized formulation .Conclusion: The pluronic F68 with the co-solvent showed fairly high entrapment efficiency, loading capacity than the mixed Pluronic in combination
洛匹那韦聚合物胶束的制备、开发与评价
洛匹那韦是一种抗HIV药物,用于治疗HIV-1感染。在这项研究中,我们使用单洛匹那韦药物来制备聚合物胶束。本研究主要有两个目的:一是为了提高BCS IV类药物的溶解度和生物利用度,二是为了避免洛匹那韦和利托那韦合用,并使用单个洛匹那韦制备聚合物胶束,同时避免口服给药的缺点。方法:选择不同的pluronic (F188 & f127)和助溶剂(Tween80),用不同的药聚合物比制备胶束,并分别加入或不加入助溶剂和药物洛匹那韦。采用临界胶束浓度(CMC)值、胶束大小、DSC、XRD、载药率、载药率、稳定性等指标对配方进行表征。结果:经优化后得到的混合胶束(亲疏水)的包封率最高,为29%,囊泡大小为0.156µm。并对洛匹那韦和优化后的配方进行了DSC、FTIR、XRD研究。结论:与复配溶剂相比,复配溶剂的复配F68包封率和载药量均较高
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信